Inhibikase Therapeutics Inc
NASDAQ:IKT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Inhibikase Therapeutics Inc
NASDAQ:IKT
|
US |
|
Nomura Real Estate Holdings Inc
TSE:3231
|
JP |
|
Orix Corp
TSE:8591
|
JP |
|
International Game Technology PLC
NYSE:IGT
|
UK |
|
Publicis Groupe SA
PAR:PUB
|
FR |
|
Korea Zinc Inc
KRX:010130
|
KR |
|
B
|
Bitfarms Ltd
NASDAQ:BITF
|
CA |
|
T
|
Teads BV
NASDAQ:TEAD
|
NL |
|
Orthofix Medical Inc
NASDAQ:OFIX
|
US |
|
S
|
South32 Ltd
LSE:S32
|
AU |
|
Samsung Electro-Mechanics Co Ltd
KRX:009150
|
KR |
|
Biotalys NV
XBRU:BTLS
|
BE |
|
C
|
CDL Hospitality Trusts
OTC:CDHSF
|
SG |
|
G
|
Gencor Industries Inc
AMEX:GENC
|
US |
|
R
|
Rhoen Klinikum AG
SWB:RHK
|
DE |
Intrinsic Value
The intrinsic value for
Inhibikase Therapeutics Inc (IKT) under the Base Case is hidden
USD.
Compared with the current market price of 1.71 USD, the stock appears hidden
.
IKT looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether IKT usually does or if today's premium is unusual.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Inhibikase Therapeutics Inc.
The intrinsic value for
Inhibikase Therapeutics Inc (IKT) under the Base Case is hidden USD.
Compared with the current market price of 1.71 USD, the stock appears hidden.